Anemia
Dr. Masarova spoke with HemeToday on findings from a treatment comparison of pacritinib and momelotinib in myelofibrosis.
Testosterone replacement therapy improved anemia remission and new anemia prevention versus placebo in men with hypogonadism.
A study indicates that blood transfusions for anemic patients hospitalized with heart attack may improve patient outcomes.
Fostamatinib improved hemoglobin response in warm antibody autoimmune hemolytic anemia versus placebo in the FORWARD trial.
Plasma thrombopoietin was significantly higher in aplastic anemia and myelodysplastic syndromes compared with control values.
HSCT from a haploidentical donor and PTCy improved neutrophil and platelet engraftment compared with UCBT in aplastic anemia.
Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH.
Anemia appeared to increase risk of dementia and cognitive decline, and concurrent high CRP levels may further increase risk.
Advertisement
Expert Interviews on Hematology
Advertisement
